CLGN - Company ID 0001631487
CollPlant Biotechnologies Ltd trades as CLGN. In its fiscal 2025 annual report the company posted revenue of $2.37M, up 360.4% from the prior year and net income of -$11.49M. This page tracks CollPlant Biotechnologies Ltd through 317 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 7 fiscal years CollPlant Biotechnologies Ltd's revenue declined from $5.01M to $2.37M, a compound annual decline rate of 10.1%. Net profit margin compressed from -124.6% to -484.6% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| New insider ownership | 3 | 2026-04-27 |
| EFFECT | - | 2026-04-21 |
| 424B3 | - | 2026-04-21 |
| Company correspondence | CORRESP | 2026-04-17 |
| F-1/A | - | 2026-04-15 |
| 6-K | - | 2026-04-13 |
| SEC correspondence | UPLOAD | 2026-04-01 |
| F-1 | - | 2026-03-30 |
The largest companies sharing CollPlant Biotechnologies Ltd's SEC industry classification (orthopedic, prosthetic & surgical appliances & supplies).
CollPlant Biotechnologies Ltd reported revenue of $2.37M for fiscal year 2025, an increase of 360.4% year over year.
In its latest fiscal year CollPlant Biotechnologies Ltd reported a net loss of $11.49M.